Evidence map›Paper›PMID 37580573›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2024

Low-dose radiotherapy for greater trochanteric pain syndrome-a single-centre analysis.

Michal Staruch, Silvia Gomez, Susanne Rogers, Istvan Takacs, Thomas Kern, Sabine Adler, Dieter Cadosch, Oliver Riesterer

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Radiotherapy for painful shoulder syndrome: a retrospective evaluation.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Michal StaruchCenter for Radiation Oncology KSA-KSB, Kantonsspital Aarau, 5001, Aarau, Switzerland. michal.staruch@ksa.ch.ORCID 0000-0003-2244-1811
Silvia GomezCenter for Radiation Oncology KSA-KSB, Kantonsspital Aarau, 5001, Aarau, Switzerland.
Susanne RogersCenter for Radiation Oncology KSA-KSB, Kantonsspital Aarau, 5001, Aarau, Switzerland.
Istvan TakacsCenter for Radiation Oncology KSA-KSB, Kantonsspital Baden, 5404, Baden, Switzerland.
Thomas KernCenter for Radiation Oncology KSA-KSB, Kantonsspital Aarau, 5001, Aarau, Switzerland.
Sabine AdlerDepartment of Rheumatology, Kantonsspital Aarau, 5001, Aarau, Switzerland.
Dieter CadoschDepartment of Orthopaedic and Traumatology, Kantonsspital Aarau, 5001, Aarau, Switzerland.
Oliver RiestererCenter for Radiation Oncology KSA-KSB, Kantonsspital Aarau, 5001, Aarau, Switzerland.
Kantonsspital Aarau · CHKantonsspital Baden · CHUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine predictive factors associated with a good response (GR) to and efficacy of low-dose radiotherapy (LDRT) in patients with greater trochanteric pain syndrome (GTPS).

methodsPatients with GTPS were irradiated on a linear accelerator with 0.5-1.0 Gy per fraction to a total dose of 3.0-4.0 Gy per series. The endpoint was subjective good response (GR) to treatment 2 months after completion of the last LDRT series, defined as complete pain relief or marked improvement assessed using the von Pannewitz score. A positive response to steroid injection (SI) was defined as pain relief of at least 7 days. Patient and treatment-related characteristics were evaluated with respect to LDRT outcomes.

resultsOutcomes were assessed for 71 peritrochanteric spaces (PTSs; 65 patients, 48 females, with mean age of 63 [44-91] years). Prior SI had been given to 55 (77%) PTSs and 40 PTSs received two series of LDRT. Two months after completion of LDRT, GR was reported in 42 PTSs (59%). Two series of LDRT provided a significantly higher rate of GR than one series (72.5 vs. 42% PTSs, p = 0.015). Temporary pain relief after prior SI predicted GR to LDRT compared with PTSs which had not responded to SI (73 vs. 28% PTSs, p = 0.001). A regional structural abnormality, present in 34 PTSs (48%), was associated with a reduction of GR to LDRT (44 vs. 73% PTSs, p = 0.017).

conclusionLDRT is an effective treatment for GTPS. Administration of two LDRT series, prior response to SI, and absence of structural abnormalities may predict significantly better treatment outcomes.

Indexed as

BursitisFemaleHumansMiddle AgedPainTreatment OutcomeBenign diseaseGreater trochanteric pain syndromeLow-dose radiation therapyRadiotherapyTrochanteric bursitis

Identifiers

PMID37580573
PMCPMC10805988
OpenAlexW4385812365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.